A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis

This study has been completed.

Study NCT00658567 Information provided by ACADIA Pharmaceuticals Inc.

First Received: April 10, 2008 Last Updated: August 4, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	December 2009 (Final data collection date for primary outcome measure)